Global Cord Blood (CORBF) Competitors $1.00 -0.01 (-0.99%) As of 02:35 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrends CORBF vs. ACONW, AONC, BTTX, DHACW, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, and NTRAShould you be buying Global Cord Blood stock or one of its competitors? The main competitors of Global Cord Blood include Aclarion (ACONW), American Oncology Network (AONC), Better Therapeutics (BTTX), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), and Natera (NTRA). These companies are all part of the "healthcare" industry. Global Cord Blood vs. Aclarion American Oncology Network Better Therapeutics Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute Natera Aclarion (NASDAQ:ACONW) and Global Cord Blood (NYSE:CORBF) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, community ranking, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk. Does the MarketBeat Community prefer ACONW or CORBF? Aclarion and Global Cord Blood both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAclarionN/AN/AGlobal Cord BloodN/AN/A Which has higher valuation and earnings, ACONW or CORBF? Global Cord Blood has higher revenue and earnings than Aclarion. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$49.29KN/AN/AN/AN/AGlobal Cord Blood$196.12MN/A$79.04MN/AN/A Is ACONW or CORBF more profitable? Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A Global Cord Blood N/A N/A N/A Does the media prefer ACONW or CORBF? In the previous week, Aclarion had 6 more articles in the media than Global Cord Blood. MarketBeat recorded 6 mentions for Aclarion and 0 mentions for Global Cord Blood. Aclarion's average media sentiment score of 0.27 beat Global Cord Blood's score of 0.00 indicating that Aclarion is being referred to more favorably in the media. Company Overall Sentiment Aclarion Neutral Global Cord Blood Neutral SummaryAclarion beats Global Cord Blood on 2 of the 3 factors compared between the two stocks. Get Global Cord Blood News Delivered to You Automatically Sign up to receive the latest news and ratings for CORBF and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CORBF vs. The Competition Export to ExcelMetricGlobal Cord Bloodhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE ExchangeMarket CapN/A$2.33B$5.61B$20.34BDividend YieldN/A7.65%5.36%3.61%P/E RatioN/A17.9089.7742.06Price / SalesN/A8.911,229.1016.68Price / Cash1.529.5844.3020.35Price / BookN/A3.295.125.92Net Income$79.04M$65.07M$117.86M$1.01B7 Day Performance-0.99%-0.12%1.84%0.47%1 Month Performance-33.33%11.80%7.95%5.55%1 Year Performance-20.00%-12.81%26.54%17.40% Global Cord Blood Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CORBFGlobal Cord BloodN/A$1.00-1.0%N/A-19.2%$0.00$196.12M0.001,200ACONWAclarionN/A$0.03-6.9%N/A-57.4%$0.00$49,289.000.007Gap UpAONCAmerican Oncology NetworkN/A$5.39+1.7%N/A-4.8%$0.00$1.34B0.001,520BTTXBetter TherapeuticsN/AN/AN/AN/A$0.00N/A0.0040High Trading VolumeDHACWDigital Health AcquisitionN/A$0.05-9.4%N/A-44.5%$0.00N/A0.00N/AGap UpLFMDPLifeMDN/A$21.86-1.8%N/A+17.6%$0.00$193.06M0.00230Short Interest ↑OTRKPOntrakN/A$0.25flatN/A-56.0%$0.00$10.84M0.00250PIIIWP3 Health PartnersN/A$0.02+55.3%N/A-61.5%$0.00$1.48B0.00500Short Interest ↓News CoverageTALKWTalkspaceN/A$0.15flatN/A-11.3%$0.00$181.29M0.00500Short Interest ↓TOIIWOncology InstituteN/A$0.02+25.0%N/A-79.4%$0.00$378.93M0.00660Short Interest ↓Positive NewsNTRANatera2.5257 of 5 stars$158.36-6.0%$160.63+1.4%+153.3%$20.91B$1.08B-89.983,293Analyst ForecastInsider TradeHigh Trading Volume Related Companies and Tools Related Companies ACONW Competitors AONC Competitors BTTX Competitors DHACW Competitors LFMDP Competitors OTRKP Competitors PIIIW Competitors TALKW Competitors TOIIW Competitors NTRA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CORBF) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredTrump’s back in the oval office. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. And he says 2025 could be...Weiss Ratings | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Global Cord Blood With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
